Reproduction permitted for personal use only. For reprints and reprint permission, contact email@example.com.
- Platypus Technologies
, a provider of nanotechnology-based products for the biotechnology industry, has announced the appointment of University of Wisconsin-Madison
graduate and former Promega Corp.
executive Jeff Williams as chief executive officer.
He will succeed company co-founder Barb Israel, who will serve the organization as a board member and a consultant.
Prior to joining Platypus, Williams served as senior vice president and was in charge of product development at Asuragen
, an oncology molecular diagnostic company based in Austin, Texas.
Before joining Asuragen, Williams was vice president and general manager of Ambion Diagnostics
, where he was responsible for the commercialization of several FDA-regulated diagnostic products.
He also spent more than 10 years at Roche Diagnostics
, which recently acquired the Madison-based NimbleGen Systems
, and spent six years as director of operations with Promega Corp.
Williams received both his Bachelor of Science and PhD degrees from UW-Madison.
Platypus, which is located in the Fitchburg Technology Campus, has 23 employees.Related stories
BIO 2007: Wisconsin makes its presence felt
State pledges $50K to NovaScan, Platypus
Platypus Technologies secures $450K SBIR grant
Platypus ready to unveil new commercial lines
Platypus gets $1.6 million grant for liquid crystal tech